Clinical course of hepatitis C virus during the first decade ofinfection: cohort study

xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40"> Clinical course of hepatitis C virus during the first decade of infection: cohort study

http://bmj.com/cgi/content/abstract/324/7335/450

 

BMJ 2002;324:450 ( 23 February )

Papers

Clinical course of hepatitis C virus during the first decade of infection: cohort study

Helen E Harris, research associate,  Mary E Ramsay, consultant epidemiologist,  Nick Andrews, statistician,  Keith P Eldridge, research assistant, 

Public Health Laboratory Service Communicable Disease Surveillance Centre, London NW9 5EQ

Correspondence to: H E Harris hharris@phls.nhs.uk

Objective: To determine the clinical course of hepatitis C virus in the first decade of infection in a group of patients who acquired their infections on a known date.
Design: Cohort study.
Setting: Clinical centres throughout the United Kingdom.
Participants: 924 transfusion recipients infected with the hepatitis C virus (HCV) traced during the HCV lookback programme and 475 transfusion recipients who tested negative for antibodies to HCV (controls).
Main outcome measures: Clinical evidence of liver disease and survival after 10 years of infection.
Results: All cause mortality was not significantly different between patients and controls (Cox's hazards ratio 1.41, 95% confidence interval 0.95 to 2.08). Patients were more likely to be certified with a death related to liver disease than were controls (12.84, 1.73 to 95.44), but although the risk of death directly from liver disease was higher in patients than controls this difference was not significant (5.78, 0.72 to 46.70). Forty per cent of the patients who died directly from liver disease were known to have consumed excess alcohol. Clinical follow up of 826 patients showed that liver function was abnormal in 307 (37.2%), and 115 (13.9%) reported physical signs or symptoms of liver disease. Factors associated with developing liver disease were testing positive for HCV ribonucleic acid (odds ratio 6.44, 2.67 to 15.48), having acquired infection when older (at age >=  40 years; 1.80, 1.14 to 2.85), and years since transfusion (odds ratio 1.096 per year, 1.00 to 1.20). For patients with severe disease, sex was also significant (odds ratio for women 0.38, 0.17 to 0.88). Of the 362 patients who had undergone liver biopsy, 328 (91%) had abnormal histological results and 35 (10%) of these were cirrhotic.
Conclusions: Hepatitis C virus infection did not have a great impact on all cause mortality in the first decade of infection. Infected patients were at increased risk of dying directly from liver disease, particularly if they consumed excess alcohol, but this difference was not statistically significant.


What is already known on this topic
The clinical course of HCV infection is unclear because most information has come from studies of patients with established chronic liver disease

Studies that follow patients from disease onset are rare because most HCV infections are asymptomatic

What this study adds
HCV infection does not have a great impact on all cause mortality in the first decade of infection

Infected patients have an increased risk of dying from a liver related cause, particularly if they consumed excess alcohol



 

© BMJ 2002

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.